Patients with intertrigo in the large skin folds as the groin, submammary and axillairy will be included for a medical trial. The intertrigo has to be two-sided, so each patient can be his own controle.
Conditions
Interventions
Product Name: Zinc oxide 10% in ketoconazole
Pharmaceutical Form: Cream
Product Name: Hydrocortisone 1% and zinc oxide 10% in ketoconazole
Pharmaceutical Form: Cream
Sponsors
Medisch Centrum Leeuwarden
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Two-sided intertrigo in the groin, submammary or axillary that has not been treated yet. - After 5-7 days a revision should be possible. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - Patients may not have an affection that can be of influence for this treatment or an affection wherefor our threament has an contra-indication. - Patients can't have an hypersensibility for the given treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Reduce of area of intertrigo;Secondary Objective: reduce of local complainments checked by a scoreform and evaluation of the cultured samples taken with inclusion.;Primary end point(s): Reduce of the intertigo area | — |
Countries
Netherlands
Outcome results
None listed